Forward Pharma A/S : Results of 2023 Annual Meeting of Shareholders

RESULTS OF 2023 ANNUAL MEETING OF SHAREHOLDERS

The annual general meeting of the shareholders of Forward Pharma A/S (the "Company") was held on June 8, 2023 at the Company's offices, Østergade 24A, 1, 1100 Copenhagen K, Denmark (the "Annual Meeting"). DKK 128,061.19 of the Company's share capital and 12,806,119 votes, respectively, were represented at the Annual Meeting.

Results of the Annual Meeting were as follows:

1. The board of directors' report on the Company's activities in the past financial year was noted by the Annual Meeting.
2. Adoption of the Company's annual report by 12,687,287 votes in favour, and with 118,272 votes against and 560 abstentions.
3. Adoption of the proposal to carry forward the result for the accounting year 2022 to the next financial year by 12,687,455 votes in favour, and with 118,272 votes against and 392 abstentions.
4. Approval of the discharge of the board of directors and the management board by 12,681,911 votes in favour, 122,808 against and 1,400 abstentions.
5. Election of members to the board of directors:
   Re-election of the following members to the board of directors as follows:
6. • Florian Schönharting (11,821,961 votes in favour and 984,158 abstentions)
   • Duncan Moore (11,807,065 votes in favour and 999,054 abstentions)
   • Torsten Goesch (11,485,961 votes in favour and 1,320,158 abstentions)
   • Grant Hellier Lawrence (11,821,961 votes in favour and 984,158 abstentions)
   • Jakob Mosegaard Larsen (11,821,961 votes in favour and 984,158 abstentions)
7. Approval of PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab as the Company's new auditor with 11,821,961 votes in favour, and with 0 votes against and 984,158 abstentions.
8. Adoption of the proposal to approve the following amendments to the articles of association by 11,820,169 votes in favour, and with 984,158 votes against and 1,792 abstentions.